Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 53)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
30-Nov-09Freedonia Group Inc, TheThe Freedonia GroupFreedonia Focus on Cancer Therapies23$500  View Abstract
24-Nov-09New Constructs, LLCN/ACEPH: Updated Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299  View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Trends, Statistics & Analysis 2010 (Summary)98$199  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)148$169  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)103$169  View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)101$169  View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 10)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
11-Nov-09Thomson StreetEventsN/ACEPH - Event Transcript of Cephalon, Inc. conference call, Nov. 10, 2009 / 12:00pm ET41$75  View Abstract
10-Nov-09Collins Stewart LLCLouise ChenR&D Day and Rummel Data Both Good for CEPH12$25  View Abstract
28-Oct-09Thomson StreetEventsN/ACEPH - Event Transcript of Cephalon, Inc. conference call, Oct. 27, 2009 / 5:00pm ET22$75  View Abstract
28-Oct-09Thomson StreetEventsN/ACEPH - Event Brief of Cephalon, Inc. conference call, Oct. 27, 2009 / 5:00pm ET23$75  View Abstract
28-Oct-09Collins Stewart LLCLouise Chen3Q09 EPS Beat, 2010 Guidance In-Line, Focus on Pipeline13$50  View Abstract
26-Oct-09Collins Stewart LLCLouise ChenBioAssets Deal Good for CEPH2$10  View Abstract
21-Oct-09Collins Stewart LLCLouise ChenANDA Filing for Nuvigil Removes An Overhang on CEPH Shares2$10  View Abstract
16-Oct-09Collins Stewart LLCLouise ChenNovember 2009 Stock Catalysts22$75  View Abstract
15-Oct-09Collins Stewart LLCLouise ChenKey Takeaways From IMS Review of Worldwide Pharma Market in 20108$25  View Abstract
30-Mar-09First GlobalLe Grand FromagFirst Global's Le Grand Fromage: Eats shoots and leaves6$30  View Abstract

Independent Reports (Showing 1 to 10 of 43)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
30-Nov-09Freedonia Group Inc, TheThe Freedonia GroupFreedonia Focus on Cancer Therapies23$500View Abstract
24-Nov-09New Constructs, LLCN/ACEPH: Updated Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299View Abstract
23-Nov-09Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Trends, Statistics & Analysis 2010 (Summary)98$199View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (Global)148$169View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)103$169View Abstract
22-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)101$169View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.